Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Funds / Blackstone Life Sciences VI - B L.P.

Blackstone Life Sciences VI - B L.P.

Fundraisingbuyout or unlabelledmanager not yet resolvedDelaware
Amounts, each with its basis
Vintage
2025basis: Form D first sale
Target
unknownnot announced
First close
unknownnever inferred from a Form D
Final close
unknownonly from an announcement or an LP disclosure
Announced size
unknown
Form D offering
$6.3Bwhat may be sold, not what was raised
Form D sold
$6.3Bas of the filing of Apr 2, 2026, 1 investors
First sale
Nov 7, 2025
Reported gross assets
unknownForm ADV; not fund size, not dry powder
Peak reported gross assets
unknownhighest year on the reporting tape
Owners (ADV)
unknown
Reported on ADV
unknown
Lifecycle
Fundraising
rule: recent Form D and no reported gross assetsmodel: lc-pe-1gav path: as of year: n/aform d latest: 2026-04-02reported years: 0first reported year: n/a
Reported gross assets by year
0 annual rows
No Form ADV reporting row for this fund. It may be known from Form D only.
Placement agents and principals
0 placement agents, 16 principals
Limited partners
0 disclosed
No LP commitment to this fund collected yet. An LP appears only when a public disclosure names this fund.
Investments attributed to this fund
0
No investment attributed to this fund. A firm’s investments sit on the firm; a fund gets one only when a source names the vehicle.
Events
1 most recent
  1. Apr 2, 2026
    Blackstone Life Sciences VI - B L.P. Form D/A: Form D amount sold up $2,684,701,707 to $6,300,000,000 (previous filing $3,615,298,293)